Cambridge-based biopharmaceutical, Mogrify raises Series A funding totaling $33M
The modern pharmaceutical companies are transforming cell therapy treatment to cure fatal diseases. Mogrify, a UK-based biopharmaceutical company aiming to transform the cell therapies has...